www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

March 16, 2017

PDF Version

Supporting Materials:
FM_10_17UK_16032017.pdf

 

 

Copenhagen, 2017-03-16 12:55 CET (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions, based on the allotments of share options and conditional shares which ALK has granted in accordance with the sign on fee for the new President & CEO Carsten Hellmann adopted at the company's Annual General Meeting on 15 March 2017:

 

1.Details of the person discharging managerial responsibility / person closely associated
a)NameCarsten Hellmann
2.Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/
amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
b)LEI529900SGCREUZCZ7P020
4.Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument
Identification code
B shares

 
DK0060027142
b)Nature of the transactionAllotment based on existing programmes from 2014 and 2015 and a new programme
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 1,832,310      6,800 (2014: share options)
  DKK 1,039,500      1,125 (2014: conditional shares)
  DKK 1,450,296      5,900 (2015: share options)
  DKK 1,053,360      1,140 (2015: conditional shares)
  DKK 3,924,533     17,068 (new: share options)
d)Aggregated information
- Aggregated volume
- Price
 
32,033
DKK 9,299,999 million
e)Date of the transaction2017-01-01
f)Place of the transactionNASDAQ Copenhagen


ALK-Abelló A/S
 

For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved